Received Jan 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37AM2 | LA |
Pregnant patient at approximately 33 weeks gestation inadvertently received Arexvy (RSV vaccine not approved for use in pregnancy). Vaccine administered in error. Patient notified. No adverse maternal or fetal effects noted at time of report.